Cagrilintide

Research overview

Cagrilintide is a long-acting amylin analog in clinical development for metabolic and weight-management research. Published trials and reviews evaluate amylin receptor biology, appetite pathways, and combination approaches with incretin therapies.

Potential research areas

• ▸Amylin pathway research
• ▸Appetite/satiety signaling
• ▸Body-weight study endpoints
• ▸Combination therapy research models